Cancer Research UK logo.
SearchDonate
  • Search

A trial of a monoclonal antibody and iodine treatment (I131-KAb201) for advanced cancer of the pancreas

Overview

Cancer types:

Pancreatic cancer

Status:

Results

Phase:

Phase 1/2

Details

This trial looked at a new treatment called I131-KAb201 for advanced cancer of the pancreas.

Recruitment start: 1 December 2003

Recruitment end: 31 July 2005

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor John Neoptolemos

Supported by

Experimental Cancer Medicine Centre (ECMC)

Xenova Biomedix Ltd

Last reviewed: 23 Nov 2015

CRUK internal database number: 433

Help and support